Incorporated in 1989, Advanced Enzyme Technologies Ltd is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.
Company produces over 400 proprietary
products developed from 60 enzymes. Advanced Enzyme operate in two primary
business verticals namely Healthcare & Nutrition (human and animal) and
Bio-Processing (food and non-food).
Company has 13 patents registered in
its name and applications for registration of 4 patents are pending.
Advanced Enzyme is among top 15
companies in enzyme sales in the world and 2nd largest in India. Company has
over 20 years of fermentation experience in the production of enzymes. Company
offer these products to its more than 700 global customers across 50 countries
around the world.
Advanced Enzyme's R&D team consists of over 55 scientists, microbiologists, engineers, food technologists and biotechnologists. Company have four R&D facilities, of which two are located at Thane, and one each at Sinnar and Chino, California.
Competitive strengths of the company:
1. Integrated Company with presence
across the Enzyme Value Chain
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows
2. Strong R&D, enzyme development and manufacturing capabilities
3. Specialized Business Model with high entry barriers
4. Diversified Product Portfolio and Wide Customer Base, served by a Strong Sales, Marketing and Distribution network
5. Experienced Promoters and Strong Management Team
6. Financial stability and stable cash flows
Company Promoters:
The promoters of the company are:
1. Mr. Chandrakant Laxminarayan Rathi
2. Mr. Vasant Laxminarayan Rathi
1. Mr. Chandrakant Laxminarayan Rathi
2. Mr. Vasant Laxminarayan Rathi
|
Particulars
|
For the year/period ended (in Rs. Million)
|
||||
|
31-Mar-16
|
31-Mar-15
|
31-Mar-14
|
31-Mar-13
|
31-Mar-12
|
|
|
Total Assets
|
4,516.50
|
4,180.92
|
4,082.76
|
3,963.47
|
3,490.09
|
|
Total Revenue
|
2,946.37
|
2,242.69
|
2,404.81
|
2,241.15
|
1,748.78
|
|
Profit After Tax (PAT)
|
784.35
|
501.02
|
200.86
|
492.19
|
333.36
|
Objects of the Issue:
The
Offer consists of a Fresh Issue by the company and an Offer for Sale by the
Selling Shareholders.
1.
Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
Company will not receive any proceeds from the Offer for Sale.
2.
The Fresh Issue
The object of the fresh issue is to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA; and general corporate purposes.
The object of the fresh issue is to invest in Advanced Enzymes USA, the wholly owned subsidiary for repayment / pre-payment of certain loans availed by Advanced Enzymes USA; and general corporate purposes.
Issue Detail:
Issue
Open: Jul 20, 2016 - Jul 22, 2016
Issue Type: Book Built Issue IPO
Issue Size: Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 50.00 Cr
Issue Type: Book Built Issue IPO
Issue Size: Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 50.00 Cr
Offer for Sale of 4,034,470 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
Face Value: Rs 10 Per Equity Share
Issue Price: Rs. 880 - Rs. 896 Per Equity Share
Market Lot: 16 Shares
Minimum Order Quantity: 16 Shares
Listing At: BSE, NSE
